《妇科恶性肿瘤治疗后下肢淋巴水肿的预防与护理》团体标准解读

AbstractIn May2025，the HunanNursing Associationissed the group standardfor"Preventionand nursingoflowerlimb lymphedemaaftergynecologicmalignanttumorreatment（T/HA—025），hichstandardizesthebasicrequirementsaageent pathways，riskreeng，prevetieeasuressesment，ursingcare，andfoloupforthepreetioandursingofloei lymphedemaaftergynecologicmalignanttumortreatment.Thisarticleinterpretsthekeycontentofthestandardtohelpmedicalstaf engagedintheprevetionadursingoflympedeainarousmedalisitutiosatallvelseteruderstandndplythandad. It could providea reference for further standardizing theprevention and nursing practices of lower limb lymphedema.

Keywords gynecology; malignant tumor; lower limb lymphedema;comprehensive decongestive therapy; prevention; nursing; group standard

下肢淋巴水肿（lowerlimblymphedema，LLL）是妇科恶性肿瘤综合治疗后最常见的远期并发症之一，一旦发生，常呈进行性加重，患肢短期内显著增粗，导致外观异常和运动功能障碍；至晚期，病变可累及双下肢，反复出现丹毒等感染，最终发展为象皮肿，甚至造成肢体残疾[1-2]。（剩余12412字）